Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension

Nat Neurosci. 2024 Jan;27(1):63-77. doi: 10.1038/s41593-023-01497-z. Epub 2023 Dec 4.

Abstract

Hypertension (HTN), a disease afflicting over one billion individuals worldwide, is a leading cause of cognitive impairment, the mechanisms of which remain poorly understood. In the present study, in a mouse model of HTN, we find that the neurovascular and cognitive dysfunction depends on interleukin (IL)-17, a cytokine elevated in individuals with HTN. However, neither circulating IL-17 nor brain angiotensin signaling can account for the dysfunction. Rather, IL-17 produced by T cells in the dura mater is the mediator released in the cerebrospinal fluid and activating IL-17 receptors on border-associated macrophages (BAMs). Accordingly, depleting BAMs, deleting IL-17 receptor A in brain macrophages or suppressing meningeal T cells rescues cognitive function without attenuating blood pressure elevation, circulating IL-17 or brain angiotensin signaling. Our data unveil a critical role of meningeal T cells and macrophage IL-17 signaling in the neurovascular and cognitive dysfunction in a mouse model of HTN.

MeSH terms

  • Angiotensin II
  • Animals
  • Cognitive Dysfunction*
  • Hypertension*
  • Interleukin-17
  • Mice
  • Sodium Chloride, Dietary
  • T-Lymphocytes

Substances

  • Interleukin-17
  • Angiotensin II
  • Sodium Chloride, Dietary